Latest & greatest articles for Disseminated Intravascular Coagulation

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Disseminated Intravascular Coagulation or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Disseminated Intravascular Coagulation and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Disseminated Intravascular Coagulation

1. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis Full Text available with Trip Pro

The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis The benefits and harm caused by anticoagulant treatments for sepsis induced disseminated intravascular coagulation (DIC) remain unclear. Therefore, we performed a network meta-analysis to assess the effect of available anticoagulant treatments on patient mortality, DIC resolution and the incidence of bleeding complication in patients with septic DIC.We considered all studies from four

2018 EvidenceUpdates

2. Disseminated Intravascular Coagulation After Embolization to Treat Acutely Bleeding Bilateral Massive Angiomyolipoma: A Case Report Full Text available with Trip Pro

Disseminated Intravascular Coagulation After Embolization to Treat Acutely Bleeding Bilateral Massive Angiomyolipoma: A Case Report Background: Hemorrhage from an angiomyolipoma (AML) of the kidney can be life threatening and arterial embolization is the primary treatment. Embolization is less invasive than surgery, is well tolerated, and major complications are rare. We describe a case of disseminated intravascular coagulation (DIC) after embolization of a bleeding renal AML in a 44-year-old

2018 Journal of endourology case reports

3. Risk factors for disseminated intravascular coagulation in patients with lung cancer Full Text available with Trip Pro

Risk factors for disseminated intravascular coagulation in patients with lung cancer The mortality rate from disseminated intravascular coagulation (DIC) is higher in patients with lung cancer than in non-lung cancer patients. Moreover, the prevalence of DIC varies among the pathologic types of lung cancer. This study analyzed the relationship between coagulation factors and the pathologic types of lung cancer.Twenty-six patients with progressive, inoperable stage IIB or higher lung cancer (20 (...) patients and the control group, but not among the pathologic types of lung cancer. Thrombomodulin levels were significantly higher in patients with Adeno and squamous cell carcinoma than in those with small cell carcinoma (P < 0.05 and P < 0.01, respectively). Antithrombin levels were significantly lower in patients with squamous cell carcinoma than in those with Adeno (P < 0.05).Coagulation disorders may develop secondary to chronic inflammation in patients with progressive lung cancer. DIC in lung

2018 Thoracic cancer

4. A summary of the Japan septic disseminated intravascular coagulation study Full Text available with Trip Pro

A summary of the Japan septic disseminated intravascular coagulation study Over the past few decades, the large, international, randomized controlled trials of anticoagulant therapies for patients with sepsis have not yielded any improvement in mortality rates. However, in Japan, anticoagulant therapies are administered for sepsis patients with disseminated intravascular coagulation (DIC), but not for sepsis patients without DIC. Furthermore, epidemiological data regarding sepsis in Japan (...) are scarce. Therefore, a nationwide multicenter retrospective observational study, the Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study, was undertaken. The JSEPTIC DIC study enrolled 42 intensive care units and included 3,195 patients with sepsis. The results of the JSEPTIC DIC study indicated the following: (i) anticoagulant therapy may be effective in sepsis-induced DIC patients at high risk for death, (ii) recombinant human soluble thrombomodulin administration and antithrombin

2018 Acute medicine & surgery

5. Low molecular weight heparin versusunfractionated heparin for neonatal sepsis complicated with disseminated intravascular coagulation: a systematic review and meta-analysis

Low molecular weight heparin versusunfractionated heparin for neonatal sepsis complicated with disseminated intravascular coagulation: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2018 PROSPERO

6. What criteria should be used to assess disseminated intravascular coagulation? A systematic review and meta-analysis

What criteria should be used to assess disseminated intravascular coagulation? A systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2017 PROSPERO

7. Meta-analysis of antithrombin treatment effects on mortality in sepsis and disseminated intravascular coagulation

Meta-analysis of antithrombin treatment effects on mortality in sepsis and disseminated intravascular coagulation Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence

2017 PROSPERO

9. Disseminated intravascular coagulation

Disseminated intravascular coagulation Disseminated intravascular coagulation - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Disseminated intravascular coagulation Last reviewed: February 2019 Last updated: November 2017 Summary An acquired syndrome characterised by activation of coagulation pathways, resulting in formation of intravascular thrombi and depletion of platelets and coagulation factors. Clinical history (...) level. Aggressive treatment of the underlying disorder is indicated, as well as fresh frozen plasma, platelet concentrate, antithrombin III, tissue factor pathway inhibitor, heparin, and recombinant factor VII activated for refractory haemorrhagic episodes. Complications include life-threatening haemorrhage, acute renal failure, and gangrene and loss of digits. Definition Disseminated intravascular coagulation (DIC) is an acquired syndrome characterised by activation of coagulation pathways

2017 BMJ Best Practice

10. Life‐threatening urethral hemorrhage after placement of a Foley catheter in a patient with uroseptic disseminated intravascular coagulation due to chronic urinary retention induced by untreated benign prostatic hyperplasia Full Text available with Trip Pro

Life‐threatening urethral hemorrhage after placement of a Foley catheter in a patient with uroseptic disseminated intravascular coagulation due to chronic urinary retention induced by untreated benign prostatic hyperplasia A 77-year-old man with severe septic disseminated intravascular coagulation following urinary infection was transported to our hospital. He had developed urinary retention induced by untreated prostatic hyperplasia. Immediate drainage with a Foley catheter was successfully (...) intravascular coagulation.This case report illustrates the risk of placement of Foley catheters in patients with severe septic disseminated intravascular coagulation.

2016 Acute medicine & surgery

11. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. (Abstract)

Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. Disseminated intravascular coagulation (DIC) is an acquired syndrome characterized by systemic intravascular activation of coagulation, leading to deposition of fibrin in the bloodstream. It may occur in patients with acute and chronic leukemia and is particularly associated with acute promyelocytic leukemia (a subtype of acute myeloid leukemia).To assess the clinical benefits and harms of any

2015 Cochrane

12. A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2014 PedsCCM Evidence-Based Journal Club

13. Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. (Abstract)

Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. Disseminated intravascular coagulation (DIC) is an acquired syndrome characterized by systemic intravascular activation of coagulation, leading to deposition of fibrin in the bloodstream, that may occur in patients with acute and chronic leukemia.To assess the clinical effectiveness and safety of any pharmacological intervention for treating DIC in acute or chronic leukemia.The search strategy (...) the effectiveness of interventions for treating disseminated intravascular coagulation (DIC) in patients with acute and chronic leukemia.Two review authors independently performed study selection, risk of bias assessment and data extraction.Four RCTs (126 participants) met the inclusion criteria. These trials evaluated the human activated protein C, recombinant human soluble thrombomodulin, tranexamic acid and dermatan sulphate. Included RCTs reported data on mortality and bleeding. The included RCTs were

2011 Cochrane

14. Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum. (Abstract)

Haematological interventions for treating disseminated intravascular coagulation during pregnancy and postpartum. Disseminated intravascular coagulation (DIC) is an acquired syndrome characterised by systemic intravascular activation of coagulation. There are several obstetric causes of DIC during pregnancy and postpartum.To assess the clinical effectiveness and safety of haematological interventions such as heparins (low molecular weight heparin (LMWH) and unfractionated heparin (UFH

2011 Cochrane

15. Disseminated intravascular coagulation score is associated with mortality for children with shock

Disseminated intravascular coagulation score is associated with mortality for children with shock PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2009 PedsCCM Evidence-Based Journal Club

16. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey Full Text available with Trip Pro

Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey To survey the natural history of disseminated intravascular coagulation (DIC) in patients diagnosed according to the Japanese Association for Acute Medicine (JAAM) DIC scoring system in a critical care setting.Prospective, multicenter study during a 4-month period.General critical care center

2008 EvidenceUpdates

17. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis

A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2006 DARE.

18. CLOTTING CHANGES, INCLUDING DISSEMINATED INTRAVASCULAR COAGULATION, DURING RAPID RENAL-HOMOGRAFT REJECTION Full Text available with Trip Pro

CLOTTING CHANGES, INCLUDING DISSEMINATED INTRAVASCULAR COAGULATION, DURING RAPID RENAL-HOMOGRAFT REJECTION 4193841 1970 09 06 2018 11 13 0028-4793 283 8 1970 Aug 20 The New England journal of medicine N. Engl. J. Med. Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection. 383-90 Starzl T E TE Boehmig H J HJ Amemiya H H Wilson C B CB Dixon F J FJ Giles G R GR Simpson K M KM Halgrimson C G CG eng A-6344 NIAAA NIH HHS United States T32 AI007007 (...) AI NIAID NIH HHS United States Journal Article United States N Engl J Med 0255562 0028-4793 0 Antibodies 0 Antibodies, Heterophile 0 Blood Coagulation Factors 0 Immunoglobulin G 0 Immunoglobulins 0 gamma-Globulins AIM IM Adult Antibodies analysis Antibodies, Heterophile analysis Antigen-Antibody Reactions Blood Cell Count Blood Coagulation Disorders etiology immunology Blood Coagulation Factors analysis Blood Coagulation Tests Blood Platelets Disseminated Intravascular Coagulation Female

1970 NEJM